Miha Japelj
Miha Japelj publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and Characterization of Heterocyclic Compounds, Synthesis and Reactions of Organic Compounds and Synthesis and biological activity.
- World rank
- #6,969,961 of 7,710,434 ranked researchers
- Rank in Slovenia
- #8,523 of 9,404
- Works
- 39
- Citations
- 248
- Citations per work
- 6.4
What does Miha Japelj research?
Miha Japelj's work is mostly in Chemistry (60%), Medicine (9%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2461.3%
- Chemistry2359.5%
- Engineering11.8%
- Everything else821.6%
- Health Sciences49.0%
- Medicine49.0%
- Life Sciences38.1%
- 1Organic Chemistry58% of their works
- 2Molecular Biology8% of their works
- 3Pharmacology6% of their works
- 4Cardiology and Cardiovascular Medicine3% of their works
- 5Spectroscopy2% of their works
- 6Biomedical Engineering2% of their works
Research topics
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Reactions of Organic Compounds
- Synthesis and biological activity
- Synthesis of β-Lactam Compounds
- Antibiotics Pharmacokinetics and Efficacy
- Synthesis and Catalytic Reactions
- Synthesis of heterocyclic compounds
- Synthesis and Biological Evaluation
Which keywords describe Miha Japelj's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Biological Evaluation, Anticancer Agents, Medicinal Chemistry, Catalyst, Antimicrobial and Triazines.
- Antimicrobial Activity
- Catalytic
- Amination
- Antibiotic Pharmacokinetics
- Tubulin Inhibitors
- Asymmetric Catalysis
- Imidazoles
- Triazines
- Catalyst
- Anticancer Agents
- Heterocycles
- Synthesis
- Biological Evaluation
- Medicinal Chemistry
- Antimicrobial
- Heterocyclic Compounds
- Oxazolones
- Stereocontrolled Synthesis
- Vascular Targeting Agents
- Critically Ill Patients
- Annulation
- Ketene Dithioacetal
- Quinoxaline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Synthesis406 topics
- Heterocycles263 topics
- Biological Evaluation223 topics
- Anticancer Agents173 topics
- Medicinal Chemistry143 topics
- Catalyst132 topics
- Antimicrobial121 topic
- Triazines121 topic
- Heterocyclic Compounds102 topics
- Imidazoles101 topic
- Oxazolones101 topic
- Asymmetric Catalysis71 topic
- Stereocontrolled Synthesis71 topic
- Tubulin Inhibitors71 topic
- Vascular Targeting Agents71 topic
- Antibiotic Pharmacokinetics51 topic
- Critically Ill Patients51 topic
- Amination41 topic
- Annulation41 topic
- Catalytic41 topic
- Ketene Dithioacetal41 topic
- Antimicrobial Activity31 topic
- Quinoxaline31 topic
Where does Miha Japelj work?
Miha Japelj's main affiliation in the publication record is Krka (Slovenia), Slovenia.
How many publications and citations does Miha Japelj have?
OpenAlex counts 39 works and 248 citations for Miha Japelj, an h-index of 9, ranking #6,969,961 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miha Japelj. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.